By Profit ConfidentialThe corporate earnings growth of companies in key stock indices for the second quarter has been very weak—and…
By Profit ConfidentialIf there ever was an example illustrating why good timing is important in the investment business, it’s Tesla…
By Profit ConfidentialIt must be great to have clout in the media. We are seeing more hedge-fund types and power…
By www.CentralBankNews.info This week global monetary policy was characterized by heightened activity by smaller central banks, with four…
By MoneyMorning.com.au TECHNOLOGY: Watch This Space September 4th is the date Samsung will hold their next ‘Unpacked’ event. The last…
By MoneyMorning.com.au Today’s Money Weekend will continue our exploration into the future. We got a peek at what that might…
Article by Investazor.com Chart: DIS, Daily Remember our analysis 3 Stocks you Should keep an Eye on? Well, the price…
Source: Peter Byrne of The Life Sciences Report (8/15/13) http://www.thelifesciencesreport.com/pub/na/adventures-in-the-biotech-trade-with-jim-letourneau Jim Letourneau, publisher of Big Picture Speculator, shares tales of…
By JW Jones, OptionsTradngSignals.com In my most recent article, I discussed how I was expecting U.S. financial markets to reverse…
Source: George S. Mack of The Life Sciences Report (8/15/13) http://www.thelifesciencesreport.com/pub/na/still-time-to-catch-big-growth-in-biotech-george-zavoico Biotech has had a scorching run for more than…